Denali Therapeutics Inc (DNLI)
Cost of Revenue
$93.00K
Quarterly · Period ending: · USD
DNLI Cost of Revenue
Latest reported$93.00Kperiod ending
Latest reported$93.00Kperiod ending
DNLI Quarterly Cost of Revenue ($0.00 → $93.00K)
Quarterly cost of revenue
High-resolution chart · PNG
DNLI cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 93,000 | |
| 2,845,000 | |
| 2,866,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |